The University of Texas Health Science Center at San Antonio Listed a New Clinical Trial to Study Sacituzumab Govitecan in Recurrent Glioblastoma

Press/Media: Press / Media

PeriodSep 22 2020

Media coverage

1

Media coverage

  • TitleThe University of Texas Health Science Center at San Antonio Listed a New Clinical Trial to Study Sacituzumab Govitecan in Recurrent Glioblastoma
    Media name/outletIndia Pharma News
    CountryIndia
    Date9/22/20
    PersonsAndrew Brenner